Literature DB >> 35083170

Hypertensive Heart Failure in Asia.

Helsi Rismiati1, Hae-Young Lee1.   

Abstract

Hypertension (HT) is an important risk factor for heart failure (HF). The prevalence of HT among the HF population is higher in Asia than in other regions around the world. In Asia, HT is the most common cause of HF after ischemic heart disease. Hypertensive HF (HHF) results from structural and functional adaptations of the heart, which lead to left ventricular (LV) hypertrophy (LVH). Hypertensive LVH can cause ventricular diastolic dysfunction and becomes a risk factor for myocardial infarction, which is a well-known cause of LV systolic dysfunction. Asymptomatic systolic and diastolic LV dysfunction easily progress to clinically overt HF with other precipitating factors. Although the precise pathophysiology of HHF is still unclear, we have known that HHF can be reversed by effective control of blood pressure (BP). Thus, HT control is essential not only for primary prevention but also for the secondary prevention of HF. Here, we reviewed the epidemiology, pathophysiology, outcome, and implication of BP management in HHF patients, especially in the Asian population.
Copyright © 2021 by S. Karger AG, Basel.

Entities:  

Keywords:  Asia; Blood pressure control; Heart failure; Hypertension; Hypertensive heart failure

Year:  2021        PMID: 35083170      PMCID: PMC8739847          DOI: 10.1159/000518661

Source DB:  PubMed          Journal:  Pulse (Basel)        ISSN: 2235-8668


  69 in total

1.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  Clyde W Yancy; Mariell Jessup; Biykem Bozkurt; Javed Butler; Donald E Casey; Mark H Drazner; Gregg C Fonarow; Stephen A Geraci; Tamara Horwich; James L Januzzi; Maryl R Johnson; Edward K Kasper; Wayne C Levy; Frederick A Masoudi; Patrick E McBride; John J V McMurray; Judith E Mitchell; Pamela N Peterson; Barbara Riegel; Flora Sam; Lynne W Stevenson; W H Wilson Tang; Emily J Tsai; Bruce L Wilkoff
Journal:  J Am Coll Cardiol       Date:  2013-06-05       Impact factor: 24.094

2.  Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II.

Authors:  B Pitt; P A Poole-Wilson; R Segal; F A Martinez; K Dickstein; A J Camm; M A Konstam; G Riegger; G H Klinger; J Neaton; D Sharma; B Thiyagarajan
Journal:  Lancet       Date:  2000-05-06       Impact factor: 79.321

Review 3.  Clinical and prognostic value of hypertensive cardiac damage in the PAMELA Study.

Authors:  Cesare Cuspidi; Carla Sala; Anna Casati; Michele Bombelli; Guido Grassi; Giuseppe Mancia
Journal:  Hypertens Res       Date:  2016-11-17       Impact factor: 3.872

4.  European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-year follow-up outcomes and differences across regions.

Authors:  Maria G Crespo-Leiro; Stefan D Anker; Aldo P Maggioni; Andrew J Coats; Gerasimos Filippatos; Frank Ruschitzka; Roberto Ferrari; Massimo Francesco Piepoli; Juan F Delgado Jimenez; Marco Metra; Candida Fonseca; Jaromir Hradec; Offer Amir; Damien Logeart; Ulf Dahlström; Bela Merkely; Jaroslaw Drozdz; Eva Goncalvesova; Mahmoud Hassanein; Ovidiu Chioncel; Mitja Lainscak; Petar M Seferovic; Dimitris Tousoulis; Ausra Kavoliuniene; Friedrich Fruhwald; Emir Fazlibegovic; Ahmet Temizhan; Plamen Gatzov; Andrejs Erglis; Cécile Laroche; Alexandre Mebazaa
Journal:  Eur J Heart Fail       Date:  2016-06       Impact factor: 15.534

5.  Effects of blood pressure-lowering drugs in heart failure: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Ana-Catarina Pinho-Gomes; Luis Azevedo; Zeinab Bidel; Milad Nazarzadeh; Dexter Canoy; Emma Copland; Abdul Salam; Anthony Rodgers; Dipak Kotecha; Kazem Rahimi
Journal:  J Hypertens       Date:  2019-09       Impact factor: 4.844

6.  Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction.

Authors:  Scott D Solomon; John J V McMurray; Inder S Anand; Junbo Ge; Carolyn S P Lam; Aldo P Maggioni; Felipe Martinez; Milton Packer; Marc A Pfeffer; Burkert Pieske; Margaret M Redfield; Jean L Rouleau; Dirk J van Veldhuisen; Faiez Zannad; Michael R Zile; Akshay S Desai; Brian Claggett; Pardeep S Jhund; Sergey A Boytsov; Josep Comin-Colet; John Cleland; Hans-Dirk Düngen; Eva Goncalvesova; Tzvetana Katova; Jose F Kerr Saraiva; Małgorzata Lelonek; Bela Merkely; Michele Senni; Sanjiv J Shah; Jingmin Zhou; Adel R Rizkala; Jianjian Gong; Victor C Shi; Martin P Lefkowitz
Journal:  N Engl J Med       Date:  2019-09-01       Impact factor: 91.245

7.  Left ventricular mass and incidence of coronary heart disease in an elderly cohort. The Framingham Heart Study.

Authors:  D Levy; R J Garrison; D D Savage; W B Kannel; W P Castelli
Journal:  Ann Intern Med       Date:  1989-01-15       Impact factor: 25.391

Review 8.  Silent myocardial infarction and risk of heart failure: Current evidence and gaps in knowledge.

Authors:  Elsayed Z Soliman
Journal:  Trends Cardiovasc Med       Date:  2018-09-08       Impact factor: 6.677

9.  2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.

Authors:  Piotr Ponikowski; Adriaan A Voors; Stefan D Anker; Héctor Bueno; John G F Cleland; Andrew J S Coats; Volkmar Falk; José Ramón González-Juanatey; Veli-Pekka Harjola; Ewa A Jankowska; Mariell Jessup; Cecilia Linde; Petros Nihoyannopoulos; John T Parissis; Burkert Pieske; Jillian P Riley; Giuseppe M C Rosano; Luis M Ruilope; Frank Ruschitzka; Frans H Rutten; Peter van der Meer
Journal:  Eur Heart J       Date:  2016-05-20       Impact factor: 29.983

10.  Regional Variation of Mortality in Heart Failure With Reduced and Preserved Ejection Fraction Across Asia: Outcomes in the ASIAN-HF Registry.

Authors:  Michael R MacDonald; Wan Ting Tay; Tiew-Hwa Katherine Teng; Inder Anand; Lieng Hsi Ling; Jonathan Yap; Jasper Tromp; Gurpreet S Wander; Ajay Naik; Tachapong Ngarmukos; Bambang B Siswanto; Chung-Lieh Hung; A Mark Richards; Carolyn S P Lam
Journal:  J Am Heart Assoc       Date:  2019-12-19       Impact factor: 5.501

View more
  3 in total

1.  Chinese Herbal Medicine Reduces the Risk of Heart Failure in Hypertensive Patients: A Nationwide, Retrospective, Cohort Study.

Authors:  Chun-Ting Liu; I-Ling Hung; Chung Y Hsu; Kai-Chieh Hu; Yung-Hsiang Chen; Ming-Yen Tsai
Journal:  Front Cardiovasc Med       Date:  2022-07-11

Review 2.  Targets and management of hypertension in heart failure: focusing on the stages of heart failure.

Authors:  Huanhuan Miao; Changhong Zou; Shijie Yang; Yook-Chin Chia; Minh Van Huynh; Guru Prasad Sogunuru; Jam Chin Tay; Tzung-Dau Wang; Kazuomi Kario; Yuqing Zhang
Journal:  J Clin Hypertens (Greenwich)       Date:  2022-09       Impact factor: 2.885

3.  National Trends in Hospitalization for Ambulatory Care Sensitive Conditions among Korean Adults between 2008 and 2019.

Authors:  Hyeki Park; Mi Jung Son; Da Won Jung; Hyejin Lee; Jin Yong Lee
Journal:  Yonsei Med J       Date:  2022-10       Impact factor: 3.052

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.